RecruitingNCT07449091

Adaptability of an Undetectable = Untransmissible Model for HBV

Studying Oculocerebral hypopigmentation syndrome, Cross type

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
NYU Langone Health
Principal Investigator
AnnMarie Liapakis, MD
NYU Langone Health
Enrollment
55 target
Eligibility
18-65 years · All sexes
Timeline
20262027

Study locations (1)

Collaborators

Gilead Sciences

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07449091 on ClinicalTrials.gov

Other trials for Oculocerebral hypopigmentation syndrome, Cross type

Additional recruiting or active studies for the same condition.

See all trials for Oculocerebral hypopigmentation syndrome, Cross type

← Back to all trials